ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer
Revista Portuguesa de Pneumologia (English Edition)
◽
10.1016/s2173-5115(08)70309-9
◽
2008
◽
Vol 14
(6)
◽
pp. 803-827
◽
Cited By ~ 2
Author(s):
A. Araújo
◽
B. Parente
◽
R. Sotto-Mayor
◽
E. Teixeira
◽
T. Almodôvar
◽
...
Keyword(s):
Lung Cancer
◽
Economic Analysis
◽
Supportive Care
◽
Small Cell Lung Cancer
◽
Best Supportive Care
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Third Line
◽
Third Line Treatment
Download Full-text
Related Documents
Cited By
References
Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008; 14(6):803–827
Revista Portuguesa de Pneumologia (English Edition)
◽
10.1016/s2173-5115(09)70132-0
◽
2009
◽
Vol 15
(3)
◽
pp. 555-559
Author(s):
Wojciech Bartminski
Keyword(s):
Lung Cancer
◽
Economic Analysis
◽
Supportive Care
◽
Small Cell Lung Cancer
◽
Best Supportive Care
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Third Line
◽
Third Line Treatment
Download Full-text
Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008; 14(6):803–827
Revista Portuguesa de Pneumologia (English Edition)
◽
10.1016/s2173-5115(09)70133-2
◽
2009
◽
Vol 15
(3)
◽
pp. 560-566
Author(s):
António Araújo
Keyword(s):
Lung Cancer
◽
Economic Analysis
◽
Supportive Care
◽
Small Cell Lung Cancer
◽
Best Supportive Care
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Third Line
◽
Third Line Treatment
Download Full-text
Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: A real-world cost-effectiveness analysis
Lung Cancer
◽
10.1016/j.lungcan.2011.12.003
◽
2012
◽
Vol 76
(3)
◽
pp. 472-477
◽
Cited By ~ 19
Author(s):
Ian Cromwell
◽
Kimberly van der Hoek
◽
Suzanne C. Malfair Taylor
◽
Barbara Melosky
◽
Stuart Peacock
Keyword(s):
Lung Cancer
◽
Cost Effectiveness
◽
Supportive Care
◽
Best Supportive Care
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Effectiveness Analysis
◽
Third Line
◽
Third Line Treatment
Download Full-text
PCN52 ECONOMIC ANALYSIS OF ERLOTINIB, DOCETAXEL, PEMETREXED AND BEST SUPPORTIVE CARE AS 2ND OR 3RD LINE TREATMENT OF NON-SMALL CELL LUNG CANCER
Value in Health
◽
10.1016/s1098-3015(10)66588-6
◽
2008
◽
Vol 11
(6)
◽
pp. A476
◽
Cited By ~ 2
Author(s):
F Negreiro
◽
C Pereira
◽
H Pereira
◽
C Silva
Keyword(s):
Lung Cancer
◽
Economic Analysis
◽
Supportive Care
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Best Supportive Care
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
Download Full-text
Weekly Paclitaxel Plus Bevacizumab versus Docetaxel As Second- or Third-Line Treatment in Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Results of the IFCT-1103 ULTIMATE Study
SSRN Electronic Journal
◽
10.2139/ssrn.3410910
◽
2019
◽
Author(s):
Alexis Cortot
◽
Clarisse Audigier-Valette
◽
Olivier Molinier
◽
Sylvestre Le Moulec
◽
Fabrice Barlesi
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Weekly Paclitaxel
◽
Line Treatment
◽
Small Cell Lung
◽
Third Line
◽
Third Line Treatment
Download Full-text
Second and third line treatment in non-small cell lung cancer
Critical Reviews in Oncology/Hematology
◽
10.1016/j.critrevonc.2009.01.009
◽
2009
◽
Vol 71
(2)
◽
pp. 117-126
◽
Cited By ~ 7
Author(s):
Adolfo Favaretto
◽
Giulia Pasello
◽
Cristina Magro
◽
Clorinda Schettino
◽
Cesare Gridelli
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Third Line
◽
Third Line Treatment
Download Full-text
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study
European Journal of Cancer
◽
10.1016/j.ejca.2020.02.022
◽
2020
◽
Vol 131
◽
pp. 27-36
◽
Cited By ~ 2
Author(s):
Alexis B. Cortot
◽
Clarisse Audigier-Valette
◽
Olivier Molinier
◽
Sylvestre Le Moulec
◽
Fabrice Barlesi
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Weekly Paclitaxel
◽
Line Treatment
◽
Small Cell Lung
◽
Third Line
◽
Third Line Treatment
Download Full-text
Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001)
Molecular and Clinical Oncology
◽
10.3892/mco.2017.1154
◽
2017
◽
Vol 6
(3)
◽
pp. 409-414
◽
Cited By ~ 4
Author(s):
Masayoshi Miyawaki
◽
Katsuhiko Naoki
◽
Satoshi Yoda
◽
Sohei Nakayama
◽
Ryosuke Satomi
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Small Cell
◽
Line Treatment
◽
Oncology Group
◽
Small Cell Lung
◽
Oncology Group Study
◽
Third Line
◽
Third Line Treatment
Download Full-text
PCN2I A PHARMACOECONOMIC MODEL OF THE COST-EFFECTIVENESS OF GEFITINIB (“IRESSA”) COMPARED WITH BEST SUPPORTIVE CARE (BSC) IN THIRD-LINE TREATMENT OF PATIENTS WITH REFRACTORY ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) IN THE UK
Value in Health
◽
10.1016/s1098-3015(10)65755-5
◽
2004
◽
Vol 7
(6)
◽
pp. 675-676
◽
Cited By ~ 1
Author(s):
AE Ratcliffe
◽
SM Beard
◽
S Wolowacz
Keyword(s):
Lung Cancer
◽
Best Supportive Care
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Pharmacoeconomic Model
◽
Third Line
◽
The Uk
◽
The Cost
◽
Third Line Treatment
Download Full-text
PCN25 COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB VERSUS DOCETAXEL AS A SECOND- OR THIRD-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN KOREA
Value in Health
◽
10.1016/s1098-3015(11)73117-5
◽
2010
◽
Vol 13
(7)
◽
pp. A514
◽
Cited By ~ 1
Author(s):
YG Kim
◽
EK Lee
Keyword(s):
Lung Cancer
◽
Cost Effectiveness
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Effectiveness Analysis
◽
Third Line
◽
Third Line Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close